PM

Premnath Mesram

Director Director DIN 00247358
DIN 00247358 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Premnath Mesram

Data last updated:

Premnath Mesram was a Director at Molekule (India) Private Limited (2010–2013) and Director at Myon Pharma Limited (from 2010). The companies operate in Pharma.

DIN 00247358
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2010
Oldest Company Age 31 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Molekule (India) Private Limited U24111MH2006FTC162403
Director27 Dec 20102006Under Liquidation
Myon Pharma Limited U24232MP1995PLC009770
Director27 Dec 20101995Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Myon Pharma Limited
Molekule (India) Private Limited
Premium access

Shareholding and investment profile for Premnath Mesram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Premnath Mesram

Premnath Mesram was first appointed on 27 Dec 2010 as Director at Molekule (India) Private Limited.

Premnath Mesram held 2 earlier board appointments: Molekule (India) Private Limited (Director, 27 Dec 2010 to 05 Feb 2013); Myon Pharma Limited (Director, from 27 Dec 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available